Esperion Therapeutics Inc - Trending symbols
Latest News of Esperion Therapeutics Inc
| Date | Title | Read |
|---|---|---|
| 2025-11-06 22:30 | Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Read |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EBIT | -48,202 | 33,760 | -14,442 | 9,546 | -4,896 | -16,128 | -21,024 | 36,745 | 15,721 | |
| EBITDA | -48,192 | 33,776 | -14,416 | 9,547 | -4,869 | -16,129 | -20,998 | 36,693 | 15,695 | |
| Depreciation and Amortization | 10 | 16 | 26 | 1 | 27 | -1 | 26 | -52 | -26 | |
| Other Current Assets | 10,975 | 3,937 | 14,912 | 3,692 | 18,604 | 4,925 | 23,529 | -245,741 | -222,212 | |
| Income before Tax | -61,719 | 11,784 | -49,935 | 8,685 | -41,250 | -15,094 | -56,344 | 117,366 | 61,022 | |
| Net Income | -89,220 | 39,285 | -49,935 | 8,685 | -41,250 | -15,094 | -56,344 | 117,366 | 61,022 | |
| Operating Income | -48,605 | 11,547 | -37,058 | 9,525 | -27,533 | -14,834 | -42,367 | 114,636 | 72,269 | |
| Net Income from Continuing Operations | -61,719 | 11,784 | -49,935 | 8,685 | -41,250 | -15,094 | -56,344 | 117,366 | 61,022 | |
| Interest Expense | 14,266 | -113 | 14,153 | 176 | 14,329 | 58 | 14,387 | -28,924 | -14,537 | |
| Income Tax Expense | 13,948 | -454 | 13,494 | -520 | 12,974 | 14,527 | 27,501 | -27,552 | -51 | |
| Other Stockholders Equity | 909,403 | 4,867 | 914,270 | -914,038 | 232 | 990,238 | 990,470 | -990,543 | -73 | |
| Long-term Assets Other | 6,030 | -1,178 | 4,852 | -591 | 4,261 | 45,739 | 50,000 | -50,441 | -441 |
Comments
How you think about this?